XORTX Therapeutics discusses advanced drug therapy for kidney disease and diabetes on Money Talk Radio.

XORTX Therapeutics (NASDAQ: XRTX) is a late-stage clinical pharma firm focusing on innovative therapies for kidney disease & diabetes. Dr. Allen Davidoff discusses advanced drug therapy and investment opportunities on Money Talk Radio. The company develops uric acid-lowering agents for hypertension, insulin resistance, diabetes, metabolic syndrome, and kidney injury, targeting large markets including diabetic nephropathy & kidney injury from respiratory viruses like SARS-CoV-2.